Becker Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Becker Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,375	Closed	-$222K	–	137
2015 Q4	$222K	Sell	3,375 -325	-9%	-$20.1K	0.01%	128
2015 Q3	$209K	Hold	3,700	–	–	0.01%	127
2015 Q2	$219K	Hold	3,700	–	–	0.01%	130
2015 Q1	$231K	Hold	3,700	–	–	0.01%	130
2014 Q4	$213K	Buy	+3,700	New	+$206K	0.01%	136
2013 Q4	–	Sell	-790,242	Closed	-$29.9M	–	145
2013 Q3	$29.9M	Buy	+790,242	New	+$30.8M	1.37%	28

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Becker Capital Management's TEVA Position: Q1 2016 in Review

Becker Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 3,375 shares — an estimated $222K sold.

Becker Capital Management first reported a position in TEVA in Q3 2013 and held it in 6 quarters. The position peaked at $29.9M in Q3 2013. 836 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Becker Capital Management reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Becker Capital Management sold 3,375 Teva Pharmaceuticals shares in Q1 2016, an estimated $222K.
Becker Capital Management first reported a position in Teva Pharmaceuticals in Q3 2013 and held it in 6 quarters.
Becker Capital Management's Teva Pharmaceuticals position peaked at $29.9M in Q3 2013.
836 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Becker Capital Management's 13F filing for Q1 2016, filed 25 May 2016.